Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-01-28FDA Approved: TRIAMTERENE AND HYDROCHLOROTHIAZIDE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved a generic fixed-dose combination of triamterene and hydrochlorothiazide from Macleods Pharmaceuticals Limited under an origina…
-
FDA approval · 2025-01-28FDA Approved: NEBIVOLOL — Original Application (NorthStar RxLLC)
FDA approved the Original Application for nebivolol (NEBIVOLOL) as a generic product from NorthStar RxLLC, expanding available nebivolol opt…
-
EMA approval · 2025-01-28EMA Authorised: Telmisartan Actavis (telmisartan) — Actavis Group PTC ehf
The EMA authorised Telmisartan Actavis for the treatment of hypertension, with Actavis Group PTC ehf as the marketing authorization holder.
-
FDA approval · 2025-01-23FDA Approved: SPIRONOLACTONE — Original Application (Rising Pharma Holdings, Inc.)
The FDA approved the original application for spironolactone (generic) from Rising Pharma Holdings, Inc., authorizing the marketing of a gen…
-
EMA approval · 2025-01-17EMA Authorised: PritorPlus (telmisartan;hydrochlorothiazide) — Bayer AG
EMA authorised PritorPlus, a fixed-dose combination of telmisartan and hydrochlorothiazide, for hypertension.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA approval · 2025-01-17EMA Authorised: Kinzalkomb (telmisartan;hydrochlorothiazide) — Bayer AG
Kinzalkomb, a fixed-dose combination of telmisartan and hydrochlorothiazide, has been authorised by the EMA for the treatment of hypertensio…
-
FDA approval · 2025-01-15FDA Approved: TELMISARTAN — Original Application (Macleods Pharmaceuticals Limited)
FDA approved the original application for telmisartan from Macleods Pharmaceuticals Limited, enabling the generic version to enter the marke…
-
FDA approval · 2025-01-08FDA Approved: METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE — Original Application (Ajanta Pharma USA Inc.)
The FDA approved Ajanta Pharma USA's generic combination of metoprolol tartrate and hydrochlorothiazide under an original ANDA for the treat…
-
FDA approval · 2025-01-07FDA Approved: AMLODIPINE,VALSARTAN AND HYDROCHLOROTHIAZIDE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved Macleods' generic fixed-dose combination tablet of amlodipine, valsartan, and hydrochlorothiazide for hypertension under an ori…
-
FDA approval · 2025-01-03FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for amlodipine besylate from Ascend Laboratories, LLC. Amlodipine besylate is a generic calcium chan…
-
FDA approval · 2024-12-23FDA Approved: CLONIDINE HYDROCHLORIDE — Supplemental Application (Method Pharmaceuticals, LLC)
FDA approved a supplemental application for clonidine hydrochloride submitted by Method Pharmaceuticals, LLC.
-
FDA approval · 2024-12-23FDA Approved: FELODIPINE — Supplemental Application (Carlsbad Technology, Inc.)
FDA approved a supplemental application for Felodipine from Carlsbad Technology, Inc., indicating an update to the drug's regulatory status …
-
FDA approval · 2024-12-13FDA Approved: FUROSEMIDE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' original application for furosemide, enabling a generic version of the loop diuretic to be marketed.
-
FDA approval · 2024-11-19FDA Approved: GUANFACINE — Original Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved the original application for generic guanfacine from Unichem Pharmaceuticals (USA), Inc.
-
FDA approval · 2024-11-12FDA Approved: METOPROLOL — Supplemental Application (Baxter Healthcare Corporation)
FDA approved a supplemental application for metoprolol tartrate (metoprolol) from Baxter Healthcare Corporation. This document indicates the…
-
FDA approval · 2024-11-08FDA Approved: OLMESARTAN MEDOXOMIL — Original Application (Modavar Pharmaceuticals LLC)
FDA approved olmesartan medoxomil as a generic product from Modavar Pharmaceuticals LLC under an Original Application (ANDA) for the treatme…
-
FDA approval · 2024-11-07FDA Approved: ESMOLOL HYDROCHLORIDE — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for Esmolol Hydrochloride (generic) from Mylan Institutional LLC.
-
FDA approval · 2024-11-06FDA Approved: METOLAZONE — Original Application (Micro Labs Limited)
The FDA approved the generic METOLAZONE from Micro Labs Limited under an Original Application. This metolazone product is a thiazide-like di…
-
FDA approval · 2024-11-04FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for the fixed-dose combination of amlodipine and atorvastatin by Prasco Laboratories.
-
FDA approval · 2024-10-31FDA Approved: OLMESARTAN MEDOXOMIL — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' original application for a generic olmesartan medoxomil product.
-
FDA approval · 2024-10-18FDA Approved: LABETALOL HYDROCHLORIDE — Supplemental Application (Biocon Pharma Inc.)
FDA approved Biocon Pharma Inc.'s supplemental application for Labetalol Hydrochloride, a generic beta-blocker used to treat hypertension.
-
FDA approval · 2024-10-18FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (Alembic Pharmaceuticals Inc.)
FDA approved Alembic Pharmaceuticals' generic diltiazem hydrochloride under an Original Application (ANDA).
-
FDA approval · 2024-10-15FDA Approved: TELMISARTAN — Original Application (Lifestar Pharma LLC)
FDA approved the Original Application for Telmisartan submitted by Lifestar Pharma LLC, establishing a generic version of the antihypertensi…
-
FDA approval · 2024-10-11FDA Approved: AMLODIPINE AND VALSARTAN — Original Application (Macleods Pharmaceuticals Limited)
FDA approved Macleods' original application for a fixed-dose combination of amlodipine and valsartan as a generic product.
-
FDA approval · 2024-10-01FDA Approved: FUROSEMIDE — Supplemental Application (Phlow Corporation)
The FDA approved a supplemental application for furosemide from Phlow Corporation, authorizing an additional or revised approval for the diu…